Tranquis Therapeutics Inc.
- Address
- 3 Lagoon Drive Suite 130
Sponsor Overview
Specializations
Neuromuscular Disorders
Tranquis Therapeutics Inc. focuses on amyotrophic lateral sclerosis, with research directed toward the clinical needs of people affected by progressive motor neuron degeneration.
- Motor neuron disease
- Neuromuscular degeneration
- Functional decline
The sponsor’s current clinical activity is centered on therapeutic development for ALS, reflecting a concentrated interest in neurological conditions that affect movement, strength, and daily function.
Neurodegenerative Disease
Its research portfolio is aligned with the treatment of neurodegenerative disease, particularly disorders involving progressive loss of nerve cell function and mobility.
- Neuroprotection
- Motor function impairment
- Disease progression
Clinical interest extends to biologically driven approaches for conditions marked by ongoing neurological deterioration and disability.
Safety and Tolerability Research
The sponsor’s funded trial activity includes evaluation of safety, tolerability, and biological activity in a neurological setting.
- Adverse effects
- Clinical tolerability
- Biological response
This area reflects a therapeutic focus on establishing whether candidate treatments can be used in patients with ALS while addressing key clinical and biological endpoints.
Translational Neurology
Tranquis Therapeutics Inc. is active in translational neurology, with research aimed at linking laboratory insights to patient-focused treatment development in amyotrophic lateral sclerosis.
- Biological mechanism
- Therapeutic target
- Neurological intervention
The company’s clinical work is concentrated in the United States, supporting research in a single active site environment.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety, Tolerability, and Biological Activity of TQS-168 in Patients with Amyotrophic Lateral Sclerosis: A Phase 1B Randomized, Placebo-Controlled Study |  Latvia | Not Yet Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
1 centre- Address
- Dzirciema Iela 16, 1007 Riga
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Tranquis Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.